3 active not recruiting. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Active not recruiting 3 |
Follow Thyroid Diseases: new trials by email Literature Review of Thyroid Diseases trials Research Report on Thyroid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Efficacy of Darqeen Capsule for the Management of Hypothyroidism Associated with Female Reproductive Hormonal Imbalance Darqeen Capsule - Hypothyroidism | Early Phase 1 | Active not recruiting | Hamdard University | 50 | 2024-07-02 | 2025-02-13 |
| MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin Dapagliflozin 10mg Tab, Placebo, Levothyroxine Replacement daily - Hepatic Steato-Fibrosis, Non-Alcoholic Fatty Liver Disease | Early Phase 1 | Active not recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 50 | 2024-01-15 | 2026-08-28 |
| RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers Durvalumab (Medi4736), Radioiodine (RAI) - Thyroid Cancer | Early Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 11 | 2017-07-10 | 2026-08-11 |
Hypothyroidism (2) · Infertility, Female (1) · Non-alcoholic Fatty Liver Disease (1) · Thyroid Neoplasms (1)
Endocrine System Diseases (3) · Digestive System Diseases (1) · Endocrine Gland Neoplasms (1) · Fatty Liver (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Head and Neck Neoplasms (1) · Infertility (1) · Liver Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Urogenital Diseases (1)
Iodine-131 (1) · dapagliflozin (1) · durvalumab (1)
Hamdard University (1) · Memorial Sloan Kettering Cancer Center (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1)
India (1) · Pakistan (1) · United States (1)
Alan Ho, MD, PhD (1) · Ashu Rastogi, MD,DM (1)